{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:54:50Z","timestamp":1790812490040,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0018\/2023\/AMJ"],"award-info":[{"award-number":["0018\/2023\/AMJ"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["043\/2024\/AGJ"],"award-info":[{"award-number":["043\/2024\/AGJ"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0003\/2025\/NRP"],"award-info":[{"award-number":["0003\/2025\/NRP"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0003\/2021\/AKP"],"award-info":[{"award-number":["0003\/2021\/AKP"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Th17 cells are central drivers of autoimmune pathology, including multiple sclerosis (MS), yet the endogenous metabolic signals that shape their pathogenic differentiation remain incompletely defined. Prostaglandin D\u2082 (PGD\n                    <jats:sub>2<\/jats:sub>\n                    ) is traditionally viewed as an extracellular mediator in allergic diseases. Here, we identify PGD\n                    <jats:sub>2<\/jats:sub>\n                    as a cell-intrinsic antagonist of the nuclear receptor PPAR\n                    <jats:italic>\u03b3<\/jats:italic>\n                    , thereby promoting Th17 cell differentiation and exacerbating EAE pathology. PGD\n                    <jats:sub>2<\/jats:sub>\n                    is selectively elevated in patients with MS compared with healthy individuals. Within the MS cohort, PGD\n                    <jats:sub>2<\/jats:sub>\n                    correlates with Th17 cell frequency and disease severity. Consistent with this association, administration of PGD\n                    <jats:sub>2<\/jats:sub>\n                    increases the severity of experimental autoimmune encephalomyelitis (EAE) in mice. CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell-specific deletion of\n                    <jats:italic>Hpgds<\/jats:italic>\n                    , the key synthase for PGD\n                    <jats:sub>2<\/jats:sub>\n                    , impairs Th17 cell polarization and protects against EAE, whereas exogenous PGD\n                    <jats:sub>2<\/jats:sub>\n                    restores both Th17 cell responses and disease susceptibility. Importantly, pharmacological inhibition of HPGDS alleviates EAE symptoms in mice. Consistently, HPGDS inhibition suppresses Th17 cell differentiation in both murine and human CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells, highlighting its translational potential. Mechanistically, PGD\n                    <jats:sub>2<\/jats:sub>\n                    binds directly to histidine 266 and serine 342 within the PPAR\n                    <jats:italic>\u03b3<\/jats:italic>\n                    ligand-binding domain and suppresses its transcriptional activity, as demonstrated by site-directed mutagenesis and structure-function rescue assays in\n                    <jats:italic>Pparg<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>-\/-<\/jats:italic>\n                    <\/jats:sup>\n                    T cells. Collectively, our findings define a crucial role for the HPGDS-PGD\n                    <jats:sub>2<\/jats:sub>\n                    axis in Th17 cell-mediated autoimmunity, establishing HPGDS as a promising therapeutic target for Th17 cell-mediated autoimmune diseases such as MS.\n                  <\/jats:p>","DOI":"10.1038\/s41392-026-02937-5","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:02:47Z","timestamp":1790809367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the HPGDS-PGD2 axis to treat Th17 cell-mediated autoimmunity in multiple sclerosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Yuxin","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawai","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wende","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-2617","authenticated-orcid":false,"given":"Jianbo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3181-7198","authenticated-orcid":false,"given":"John E. J.","family":"Rasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0191-5547","authenticated-orcid":false,"given":"Olivia","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqing","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0880-958X","authenticated-orcid":false,"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4990-5997","authenticated-orcid":false,"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2937_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen, M. et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179\u2013189 (2006).","journal-title":"Immunity"},{"key":"2937_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang, S. et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature 576, 143\u2013148 (2019).","journal-title":"Nature"},{"key":"2937_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08711-2","volume":"10","author":"M Luu","year":"2019","unstructured":"Luu, M. et al. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat. Commun. 10, 760 (2019).","journal-title":"Nat. Commun."},{"key":"2937_CR4","doi-asserted-by":"publisher","first-page":"102647","DOI":"10.1016\/j.autrev.2020.102647","volume":"19","author":"T Moser","year":"2020","unstructured":"Moser, T. et al. The role of TH17 cells in multiple sclerosis: Therapeutic implications. Autoimmun. Rev. 19, 102647 (2020).","journal-title":"Autoimmun. Rev."},{"key":"2937_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Prim. 4, 43 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2937_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson, T., Barcellos, L. F. & Alfredsson, L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat. Rev. Neurol. 13, 25\u201336 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"2937_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir, H. et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173\u20131175 (2007).","journal-title":"Nat. Med."},{"key":"2937_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","volume":"172","author":"JS Tzartos","year":"2008","unstructured":"Tzartos, J. S. et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146\u2013155 (2008).","journal-title":"Am. J. Pathol."},{"key":"2937_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov, I. I. et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121\u20131133 (2006).","journal-title":"Cell"},{"key":"2937_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington, L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123\u20131132 (2005).","journal-title":"Nat. Immunol."},{"key":"2937_CR11","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.1074\/jbc.C600321200","volume":"282","author":"XO Yang","year":"2007","unstructured":"Yang, X. O. et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282, 9358\u20139363 (2007).","journal-title":"J. Biol. Chem."},{"key":"2937_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.immuni.2008.03.001","volume":"28","author":"MJ McGeachy","year":"2008","unstructured":"McGeachy, M. J. & Cua, D. J. Th17 cell differentiation: The long and winding road. Immunity 28, 445\u2013453 (2008).","journal-title":"Immunity"},{"key":"2937_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2021.12.012","volume":"55","author":"NM Chapman","year":"2022","unstructured":"Chapman, N. M. & Chi, H. Metabolic adaptation of lymphocytes in immunity and disease. Immunity 55, 14\u201330 (2022).","journal-title":"Immunity"},{"key":"2937_CR14","doi-asserted-by":"publisher","first-page":"108411","DOI":"10.1016\/j.pharmthera.2023.108411","volume":"245","author":"T Kanno","year":"2023","unstructured":"Kanno, T., Nakajima, T., Miyako, K. & Endo, Y. Lipid metabolism in Th17 cell function. Pharm. Ther. 245, 108411 (2023).","journal-title":"Pharm. Ther."},{"key":"2937_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-025-02357-x","volume":"11","author":"Z Li","year":"2026","unstructured":"Li, Z. et al. Lipid metabolism in homeostasis and disease. Signal Transduct. Target Ther. 11, 55 (2026).","journal-title":"Signal Transduct. Target Ther."},{"key":"2937_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic Instruction of Immunity. Cell 169, 570\u2013586 (2017).","journal-title":"Cell"},{"key":"2937_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","volume":"38","author":"LA Sena","year":"2013","unstructured":"Sena, L. A. et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38, 225\u2013236 (2013).","journal-title":"Immunity"},{"key":"2937_CR18","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1084\/jem.20151159","volume":"212","author":"MD Buck","year":"2015","unstructured":"Buck, M. D., O\u2019Sullivan, D. & Pearce, E. L. T cell metabolism drives immunity. J. Exp. Med. 212, 1345\u20131360 (2015).","journal-title":"J. Exp. Med."},{"key":"2937_CR19","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod, L. et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20, 1327\u20131333 (2014).","journal-title":"Nat. Med"},{"key":"2937_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","volume":"8","author":"J Park","year":"2015","unstructured":"Park, J. et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 8, 80\u201393 (2015).","journal-title":"Mucosal Immunol."},{"key":"2937_CR21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.120.316784","volume":"127","author":"D Jia","year":"2020","unstructured":"Jia, D. et al. Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages. Circ. Res. 127, 1323\u20131336 (2020).","journal-title":"Circ. Res."},{"key":"2937_CR22","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jaci.2014.09.006","volume":"135","author":"L Xue","year":"2015","unstructured":"Xue, L. et al. Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell\/neutrophil crosstalk. J. Allergy Clin. Immunol. 135, 1358\u20131366.e1351-1311 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2937_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cmet.2014.01.002","volume":"19","author":"IJ Lodhi","year":"2014","unstructured":"Lodhi, I. J. & Semenkovich, C. F. Peroxisomes: A nexus for lipid metabolism and cellular signaling. Cell Metab. 19, 380\u2013392 (2014).","journal-title":"Cell Metab."},{"key":"2937_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101117","volume":"84","author":"M Szanto","year":"2021","unstructured":"Szanto, M. et al. PARPs in lipid metabolism and related diseases. Prog. Lipid Res. 84, 101117 (2021).","journal-title":"Prog. Lipid Res."},{"key":"2937_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","volume":"86","author":"M Jurynczyk","year":"2015","unstructured":"Jurynczyk, M., Craner, M. & Palace, J. Overlapping CNS inflammatory diseases: differentiating features of NMO and MS. J. Neurol. Neurosurg. Psychiatry 86, 20\u201325 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2937_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/path.5253","volume":"248","author":"D Horikami","year":"2019","unstructured":"Horikami, D. et al. L-PGDS-derived PGD2 attenuates acute lung injury by enhancing endothelial barrier formation. J. Pathol. 248, 280\u2013290 (2019).","journal-title":"J. Pathol."},{"key":"2937_CR27","doi-asserted-by":"publisher","first-page":"15277","DOI":"10.1074\/jbc.M506431200","volume":"281","author":"K Aritake","year":"2006","unstructured":"Aritake, K. et al. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J. Biol. Chem. 281, 15277\u201315286 (2006).","journal-title":"J. Biol. Chem."},{"key":"2937_CR28","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.1074\/jbc.M808593200","volume":"284","author":"D Irikura","year":"2009","unstructured":"Irikura, D. et al. Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase. J. Biol. Chem. 284, 7623\u20137630 (2009).","journal-title":"J. Biol. Chem."},{"key":"2937_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nm.4046","volume":"22","author":"DR Withers","year":"2016","unstructured":"Withers, D. R. et al. Transient inhibition of ROR-gammat therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells. Nat. Med. 22, 319\u2013323 (2016).","journal-title":"Nat. Med."},{"key":"2937_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41392-019-0079-0","volume":"4","author":"SS Athari","year":"2019","unstructured":"Athari, S. S. Targeting cell signaling in allergic asthma. Signal Transduct. Target Ther. 4, 45 (2019).","journal-title":"Signal Transduct. Target Ther."},{"key":"2937_CR31","doi-asserted-by":"publisher","first-page":"E5444","DOI":"10.1073\/pnas.1704099114","volume":"114","author":"R Vijay","year":"2017","unstructured":"Vijay, R. et al. Virus-induced inflammasome activation is suppressed by prostaglandin D2\/DP1 signaling. Proc. Natl. Acad. Sci. USA 114, E5444\u2013E5453 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2937_CR32","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1084\/jem.20082771","volume":"206","author":"L Klotz","year":"2009","unstructured":"Klotz, L. et al. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J. Exp. Med. 206, 2079\u20132089 (2009).","journal-title":"J. Exp. Med"},{"key":"2937_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1212\/WNL.41.2_Part_1.322","volume":"41","author":"P Dore-Duffy","year":"1991","unstructured":"Dore-Duffy, P., Ho, S. Y. & Donovan, C. Cerebrospinal fluid eicosanoid levels: endogenous PGD2 and LTC4 synthesis by antigen-presenting cells that migrate to the central nervous system. Neurology 41, 322\u2013324 (1991).","journal-title":"Neurology"},{"key":"2937_CR34","first-page":"2739","volume":"59","author":"R Chinery","year":"1999","unstructured":"Chinery, R. et al. Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Cancer Res. 59, 2739\u20132746 (1999).","journal-title":"Cancer Res."},{"key":"2937_CR35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1189\/jlb.0706424","volume":"81","author":"H Sandig","year":"2007","unstructured":"Sandig, H., Pease, J. E. & Sabroe, I. Contrary prostaglandins: The opposing roles of PGD2 and its metabolites in leukocyte function. J. Leukoc. Biol. 81, 372\u2013382 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"2937_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102508","volume":"114","author":"J Zheng","year":"2020","unstructured":"Zheng, J. et al. Prostaglandin D2 signaling in dendritic cells is critical for the development of EAE. J. Autoimmun. 114, 102508 (2020).","journal-title":"J. Autoimmun."},{"key":"2937_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jneuroim.2018.06.001","volume":"321","author":"MAJ Chedrawe","year":"2018","unstructured":"Chedrawe, M. A. J. et al. Pioglitazone is superior to quetiapine, clozapine and tamoxifen at alleviating experimental autoimmune encephalomyelitis in mice. J. Neuroimmunol. 321, 72\u201382 (2018).","journal-title":"J. Neuroimmunol."},{"key":"2937_CR38","doi-asserted-by":"publisher","first-page":"11210","DOI":"10.1021\/acs.analchem.8b01873","volume":"90","author":"X Bian","year":"2018","unstructured":"Bian, X. et al. Polarity-tuning derivatization-LC-MS approach for probing global carboxyl-containing metabolites in colorectal cancer. Anal. Chem. 90, 11210\u201311215 (2018).","journal-title":"Anal. Chem."},{"key":"2937_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41423-024-01240-z","volume":"22","author":"J Tian","year":"2025","unstructured":"Tian, J. et al. Dysregulation in keratinocytes drives systemic lupus erythematosus onset. Cell Mol. Immunol. 22, 83\u201396 (2025).","journal-title":"Cell Mol. Immunol."},{"key":"2937_CR40","doi-asserted-by":"publisher","first-page":"21807","DOI":"10.1073\/pnas.0906891106","volume":"106","author":"Y Kihara","year":"2009","unstructured":"Kihara, Y. et al. Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis. Proc. Natl. Acad. Sci. USA 106, 21807\u201321812 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2937_CR41","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1021\/acs.molpharmaceut.8b01063","volume":"16","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Potent Antagonists of RORgammat, cardenolides from calotropis gigantea, exhibit discrepant effects on the differentiation of T lymphocyte subsets. Mol. Pharm. 16, 798\u2013807 (2019).","journal-title":"Mol. Pharm."},{"key":"2937_CR42","first-page":"10534","volume":"43","author":"C Wang","year":"2015","unstructured":"Wang, C. et al. SerRS-tRNASec complex structures reveal mechanism of the first step in selenocysteine biosynthesis. Nucleic Acids Res. 43, 10534\u201310545 (2015).","journal-title":"Nucleic Acids Res"},{"key":"2937_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104440","volume":"149","author":"Q Chen","year":"2019","unstructured":"Chen, Q. et al. Identification of an IKKbeta inhibitor for inhibition of inflammation in vivo and in vitro. Pharm. Res. 149, 104440 (2019).","journal-title":"Pharm. Res."},{"key":"2937_CR44","first-page":"229","volume":"12","author":"Y Zhuang","year":"2022","unstructured":"Zhuang, Y. et al. 5-arylalkynyl-2-benzoyl thiophene: A novel microtubule inhibitor exhibits antitumor activity without neurological toxicity. Am. J. Cancer Res. 12, 229\u2013246 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"2937_CR45","doi-asserted-by":"publisher","first-page":"7995","DOI":"10.1021\/acs.jmedchem.4c00128","volume":"67","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. Discovery of novel small-molecule-based potential PD-L1\/EGFR dual inhibitors with high druggability for glioblastoma immunotherapy. J. Med. Chem. 67, 7995\u20138019 (2024).","journal-title":"J. Med. Chem."},{"key":"2937_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109803","volume":"116","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Integrated analysis of ATAC-seq and RNA-seq reveals the transcriptional regulation network in SLE. Int. Immunopharmacol. 116, 109803 (2023).","journal-title":"Int. Immunopharmacol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02937-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02937-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02937-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:02:48Z","timestamp":1790809368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02937-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2937"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02937-5","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"420"}}